Two Sigma Investments’s Novartis NVS Stock Holding History

Two Sigma Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$306K	Sell	2,000 -1,000	-33%	-$153K	﹤0.01%	4065
2025 Q4	$414K	Buy	+3,000	New	+$393K	﹤0.01%	3418
2015 Q3	–	Sell	-4,464	Closed	-$393K	–	2563
2015 Q2	$393K	Buy	+4,464	New	+$410K	﹤0.01%	2260

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments's NVS Position: Q1 2026 in Review

Two Sigma Investments reduced its Novartis (NVS) stake by 8% in Q1 2026, selling an estimated $368K and leaving 27,528 shares worth $4.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.

Two Sigma Investments first reported a position in NVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $170M in Q1 2022. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Two Sigma Investments held 27,528 shares of Novartis worth $4.2M as of Q1 2026.
Two Sigma Investments sold 2,400 Novartis shares in Q1 2026, an estimated $368K.
Novartis made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2126 holding.
Two Sigma Investments first reported a position in Novartis in Q2 2013 and has held it in 35 quarters since.
Two Sigma Investments's Novartis position peaked at $170M in Q1 2022.
1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.